Human Vaccines & Immunotherapeutics (Dec 2024)
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic
Abstract
No abstracts available.Keywords
Human Vaccines & Immunotherapeutics (Dec 2024)